Apellis Pharmaceuticals Stock Target Price and Analyst Consensus
| APLS Stock | USD 19.94 0.59 2.87% |
The current analyst and expert consensus on Apellis Pharmaceuticals is Strong Buy with 8 hold recommendations. The current projected Apellis Pharmaceuticals target price consensus is 34.78 with 22 analyst opinions. One of the most common ways Apellis Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Apellis Pharmaceuticals vendors, executives, and/or customers. Apellis Pharmaceuticals recommendation module provides expert sentiment on the projected Apellis Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 5.3523.
Lowest Forecast 31.65 | Highest Forecast 38.6 | Target Price 34.78 |
It's important to approach Apellis Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Apellis Pharmaceuticals Target Price Consensus
Apellis target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Apellis Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 22 | Strong Buy |
Most Apellis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Apellis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Apellis Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationApellis Pharmaceuticals Target Price Projection
Apellis Pharmaceuticals' current and average target prices are 19.94 and 34.78, respectively. The current price of Apellis Pharmaceuticals is the price at which Apellis Pharmaceuticals is currently trading. On the other hand, Apellis Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Apellis Pharmaceuticals Market Quote on 17th of January 2026
Target Price
Analyst Consensus On Apellis Pharmaceuticals Target Price
Apellis Pharmaceuticals Analyst Ratings
Apellis Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Apellis Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Apellis Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Apellis Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Apellis Pharmaceuticals price targets
Apellis Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Apellis Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Apellis Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Apellis Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Apellis Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Apellis Pharmaceuticals is a key component of Apellis Pharmaceuticals valuation and have some predictive power on the future returns of a Apellis Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Blockchain Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Social Domain Invested few shares | |
 | Video Games Invested few shares | |
 | Synthetics Invested over 70 shares | |
 | Macroaxis Index Invested few shares |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.